178 related articles for article (PubMed ID: 27593929)
21. Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions.
Joosten SEP; Gregoricchio S; Stelloo S; Yapıcı E; Huang CF; Yavuz K; Donaldson Collier M; Morova T; Altintaş UB; Kim Y; Canisius S; Moelans CB; van Diest PJ; Korkmaz G; Lack NA; Vermeulen M; Linn SC; Zwart W
Genome Res; 2024 May; 34(4):539-555. PubMed ID: 38719469
[TBL] [Abstract][Full Text] [Related]
22. Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer.
Yoshimoto N; Toyama T; Takahashi S; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
Breast Cancer Res Treat; 2011 Nov; 130(1):331-9. PubMed ID: 21755340
[TBL] [Abstract][Full Text] [Related]
23. ESR1 inhibits ionizing radiation-induced ferroptosis in breast cancer cells via the NEDD4L/CD71 pathway.
Liu L; Zhang C; Qu S; Liu R; Chen H; Liang Z; Tian Z; Li L; Ma S; Liu X
Arch Biochem Biophys; 2022 Aug; 725():109299. PubMed ID: 35613689
[TBL] [Abstract][Full Text] [Related]
24. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
25. PSPC1 is a potential prognostic marker for hormone-dependent breast cancer patients and modulates RNA processing of ESR1 and SCFD2.
Takeiwa T; Ikeda K; Suzuki T; Sato W; Iino K; Mitobe Y; Kawabata H; Horie K; Inoue S
Sci Rep; 2022 Jun; 12(1):9495. PubMed ID: 35681031
[TBL] [Abstract][Full Text] [Related]
26. The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.
Guo K; Cui J; Quan M; Xie D; Jia Z; Wei D; Wang L; Gao Y; Ma Q; Xie K
Clin Cancer Res; 2017 Feb; 23(3):687-696. PubMed ID: 27449499
[TBL] [Abstract][Full Text] [Related]
27. A cluster of noncoding RNAs activates the ESR1 locus during breast cancer adaptation.
Tomita S; Abdalla MOA; Fujiwara S; Matsumori H; Maehara K; Ohkawa Y; Iwase H; Saitoh N; Nakao M
Nat Commun; 2015 Apr; 6():6966. PubMed ID: 25923108
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.
Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S
Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468
[TBL] [Abstract][Full Text] [Related]
29. RNA-binding protein complex LIN28/MSI2 enhances cancer stem cell-like properties by modulating Hippo-YAP1 signaling and independently of Let-7.
Zou H; Luo J; Guo Y; Liu Y; Wang Y; Deng L; Li P
Oncogene; 2022 Mar; 41(11):1657-1672. PubMed ID: 35102250
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide analysis of Musashi-2 targets reveals novel functions in governing epithelial cell migration.
Bennett CG; Riemondy K; Chapnick DA; Bunker E; Liu X; Kuersten S; Yi R
Nucleic Acids Res; 2016 May; 44(8):3788-800. PubMed ID: 27034466
[TBL] [Abstract][Full Text] [Related]
32. Knockout of RNA Binding Protein MSI2 Impairs Follicle Development in the Mouse Ovary: Characterization of MSI1 and MSI2 during Folliculogenesis.
Sutherland JM; Sobinoff AP; Gunter KM; Fraser BA; Pye V; Bernstein IR; Boon E; Siddall NA; De Andres LI; Hime GR; Holt JE; Graf T; McLaughlin EA
Biomolecules; 2015 Jun; 5(3):1228-44. PubMed ID: 26131972
[TBL] [Abstract][Full Text] [Related]
33. Estrogen-independent molecular actions of mutant estrogen receptor 1 in endometrial cancer.
Blanchard Z; Vahrenkamp JM; Berrett KC; Arnesen S; Gertz J
Genome Res; 2019 Sep; 29(9):1429-1441. PubMed ID: 31362937
[TBL] [Abstract][Full Text] [Related]
34. ESR1 gene status correlates with estrogen receptor protein levels measured by ligand binding assay and immunohistochemistry.
Laenkholm AV; Knoop A; Ejlertsen B; Rudbeck T; Jensen MB; Müller S; Lykkesfeldt AE; Rasmussen BB; Nielsen KV
Mol Oncol; 2012 Aug; 6(4):428-36. PubMed ID: 22626971
[TBL] [Abstract][Full Text] [Related]
35. Status of estrogen receptor 1 (ESR1) gene in mastopathy predicts subsequent development of breast cancer.
Soysal SD; Kilic IB; Regenbrecht CR; Schneider S; Muenst S; Kilic N; Güth U; Dietel M; Terracciano LM; Kilic E
Breast Cancer Res Treat; 2015 Jun; 151(3):709-15. PubMed ID: 25981900
[TBL] [Abstract][Full Text] [Related]
36. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J
Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of MSI2 inhibits metastasis by interacting with caveolin-1 and inhibiting its ubiquitylation in human NF1-MPNST cells.
Yang K; Du J; Shi D; Ji F; Ji Y; Pan J; Lv F; Zhang Y; Zhang J
Cell Death Dis; 2020 Jun; 11(6):489. PubMed ID: 32606289
[TBL] [Abstract][Full Text] [Related]
38. USP10 regulates Musashi-2 stability via deubiquitination and promotes tumour proliferation in colon cancer.
Ouyang SW; Liu TT; Liu XS; Zhu FX; Zhu FM; Liu XN; Peng ZH
FEBS Lett; 2019 Feb; 593(4):406-413. PubMed ID: 30604502
[TBL] [Abstract][Full Text] [Related]
39. Bone Marrow Stromal Cells Transcriptionally Repress ESR1 but Cannot Overcome Constitutive ESR1 Mutant Activity.
Lung DK; Warrick JW; Hematti P; Callander NS; Mark CJ; Miyamoto S; Alarid ET
Endocrinology; 2019 Oct; 160(10):2427-2440. PubMed ID: 31504407
[TBL] [Abstract][Full Text] [Related]
40. pRb controls estrogen receptor alpha protein stability and activity.
Caligiuri I; Toffoli G; Giordano A; Rizzolio F
Oncotarget; 2013 Jun; 4(6):875-83. PubMed ID: 23900261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
